Slingshot members are tracking this event:
Bayer Phase 3 program called RESPIRE of Cipro DPI (Cipro Dry Powder Inhaler) for Non-cystic fibrosis bronchiectasis data due 2H 2016
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|NKTR||Community voting in process|
Slingshot Insights Explained
Nov 24, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Program, Respire, Cipro Dpi, Dry Powder Inhaler, Non-cysticc Fribrosis Bronchiectasis, Ncfb, 2h 2016